Delivery Order SPE2DB20D1051-SPE2DB25FD7ZB

Award Date 5/5/25
Potential Completion Date 5/6/25
Potential Value $4.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $18,503.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, with a performance period extending until April 18, 2025. The contract is a firm fixed-price arrangement and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $1,722.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with an ultimate completion date of April 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides...
This federal contract award is for $1,638.00 and was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a period of performance through February 12, 2025. The contract is a Firm Fixed Price agreement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,228.50 fixed-price delivery order is for the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a period of performance through March 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,753.19 delivery order contract is a firm fixed-price, non-set-aside award for the supply of the prescription medication WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,525.91, is for the delivery of the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract is a Firm Fixed Price Delivery Order with a completion date of March 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $1,500.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which is not set-aside, is a delivery order contract for the medication WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,081.94 firm fixed-price delivery order contract is for the supply of the medication WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of October 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $24,979.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 17, 2024 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,446.52 firm fixed price delivery order is for the medication WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of March 21, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB20D1051
    Indefinite Delivery Contract
  • SPE2DB20D1051-SPE2DB25FD7ZB
    Delivery Order

This federal contract award, valued at $4,822.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a performance period ending on May 6, 2025. This contract is not set-aside and was awarded on a firm fixed-price basis.

AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 8/4/25, 9:55 AM